Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: A marker of activity? A case report with a 5-year follow-up

Thus, we conclude that plasma VEGF determination should be considered for diagnosis and follow-up of the course and the treatment of disseminated lymphangiomatosis-Gorham-Stout disease.